A diabetes education and community support setting.
Carolyn Rafieymehr / Wikimedia Commons / Public domain
Clinical Trials/June 24, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • Long-Term Outcomes of Teplizumab in Routine Clinical Care — RECRUITING. Interventions: Teplizumab. Locations: Atlanta, Georgia, United States | Atlanta, Georgia, United States | Syosset, New York, United States. This is an observational, prospective cohort study designed to eval...Source
  • EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes — RECRUITING, NA. Interventions: Type 1 Doing Well (T1DW) Program, Diabetes-Related Information and Resources Program. Locations: Houston, Texas, United States. The EMPoWER Study randomized clinical trial is a strengths-b...Source
  • Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes — RECRUITING, NA. Interventions: Aerobic Exercise, Resistance Exercise, No exercise. Locations: Edmonton, Alberta, Canada | Montreal, Quebec, Canada. Participants will be asked to wear a continuous glucose monitor for at...Source
  • T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes — RECRUITING, NA. Interventions: T1CARE. Locations: New Haven, Connecticut, United States | New Haven, Connecticut, United States. Randomized controlled trial with a wait list control arm. Participants will be randomized...Source
  • EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) — RECRUITING. Interventions: Beta Cell Loss and Immune Function, Immune Function with RNAseq. Locations: Seattle, Washington, United States | Leiden, Leiden, Netherlands | Exeter, Devon, United Kingdom. Type 1 diabetes (T...Source
  • Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years — RECRUITING, PHASE2. Interventions: Bacillus Calmette-Guérin, Saline Injection. Locations: Charlestown, Massachusetts, United States. The purpose of this study is to investigate if repeat bacillus Calmette-Guérin (BCG) v...Source
  • Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families — RECRUITING, NA. Interventions: R2D2 mHealth intervention. Locations: Jacksonville, Florida, United States | Kansas City, Missouri, United States. This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to I...Source
  • Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes — RECRUITING, PHASE1. Interventions: Hyperinsulinemic-euglycemic clamp, High Fat Mixed Meal Tolerance Test. Locations: New Haven, Connecticut, United States. More than 40% of young adults with type 1 diabetes (T1D) also h...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.